European public procurement and grants data from official registers · Data as of 17 November 2026; updated daily.

Grant programme · United States

Cancer Cause and Prevention Research

Cancer Cause and Prevention Research (United States): the programme's calls and grants. 112 calls on the site, 26 open now; its calls usually open in November. Data as of 17 November 2026; updated daily.

Funder: National Institutes of Health (Department of Health and Human Services)

Grants in the last 24 months
0
Recipients
0
Open calls
26
Calls on the site
112

Calls usually open in November

About the programme

Objectives: To identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans. Research programs include: (1) chemical, physical and molecular carcinogenesis;…

Read more at the source

Open calls

Grant callStatusCloses
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (round Nov 2024 – Jan 2027)Open7 January 2027
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) (round Nov 2024 – Jan 2027)Open7 January 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) (round Nov 2024 – Jan 2027)Open7 January 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) (round Nov 2024 – Jan 2027)Open7 January 2027
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)Open9 February 2027
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)Open25 May 2027
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) (round Dec 2024 – Sep 2027)Open10 September 2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) (round Nov 2024 – Oct 2027)Open8 October 2027
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) (round May 2026 – Oct 2027)Open19 October 2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) (round Nov 2024 – Nov 2027)Open16 November 2027
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) (round Nov 2024 – Jan 2028)Open7 January 2028
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) (round Nov 2024 – Jan 2028)Open7 January 2028
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) (round Nov 2024 – Jan 2028)Open7 January 2028
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) (round Sep 2024 – Jan 2028)Open7 January 2028
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) (round Dec 2024 – Jan 2028)Open7 January 2028
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) (round Nov 2024 – Jan 2028)Open7 January 2028
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) (round Sep 2024 – Jan 2028)Open7 January 2028
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)Open7 September 2028
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) (round Nov 2024 – Sep 2028)Open7 September 2028
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)Open5 July 2029
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) (round May 2026 – Jul 2029)Open5 July 2029
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)Open5 November 2029
NIH Research Center Core GrantsForthcoming—
NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)Forthcoming—
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)Forthcoming—
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)Forthcoming—

Earlier calls

Grant calendars

Grants for projects that started between 17 November 2024 and 17 November 2026; amounts in euro at the Eurostat rate of each year.

Questions and answers

When does Cancer Cause and Prevention Research open calls?
26 open now: Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) (7 January 2027), National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer… (7 January 2027), Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Opti… (7 January 2027), …. Its calls usually open in November.